Search Results - "Petra, Prins"

Regorafenib in advanced hepatocellular carcinoma (HCC): considerations for treatment by Kim, Kyung, Jha, Reena, Prins, Petra A., Wang, Hongkun, Chacha, Monica, Hartley, Marion L., He, Aiwu Ruth

“…Purpose We report our institutional observations of ten patients with advanced hepatocellular carcinoma (HCC) (seven and three were Child–Pugh class A and B,…”
Get full text

Angiotensin-induced abdominal aortic aneurysms in hypercholesterolemic mice: role of serum cholesterol and temporal effects of exposure by Prins, Petra A, Hill, Michael F, Airey, David, Nwosu, Sam, Perati, Prudhvidhar R, Tavori, Hagai, F Linton, Macrae, Kon, Valentina, Fazio, Sergio, Sampson, Uchechukwu K

“…Understanding variations in size and pattern of development of angiotensin II (Ang II)-induced abdominal aortic aneurysms (AAA) may inform translational…”
Get full text

Chronic methamphetamine exposure produces a delayed, long-lasting memory deficit by North, Ashley, Swant, Jarod, Salvatore, Michael F., Gamble-george, Joyonna, Prins, Petra, Butler, Brittany, Mittal, Mukul K., Heltsley, Rebecca, Clark, John T., Khoshbouei, Habibeh

“…Methamphetamine (METH) is a highly addictive and neurotoxic psychostimulant. Its use in humans is often associated with neurocognitive impairment. Whether this…”
Get full text

Underuse of exon mutational analysis for gastrointestinal stromal tumors by Bartholomew, Alex J., Dohnalek, Hayden, Prins, Petra A., O'Neill, Suzanne C., Quadri, Humair S., Marshall, John L., Haddad, Nadim G., Al-Refaie, Waddah B.

“…Tyrosine kinase inhibitors (TKI) have become the guideline-recommended therapy for high-risk resected and advanced gastrointestinal stromal tumors (GISTs)…”
Get full text

Pancreatic cancer, treatment options, and GI-4000 by Hartley, Marion L, Bade, Najeebah A, Prins, Petra A, Ampie, Leonel, Marshall, John L

“…Although pancreatic cancer is but the eleventh most prevalent cancer in the US, it is predicted that of all the patients newly diagnosed with this disease in…”
Get full text

Pancreatic cancer, treatment options, and GI-4000 by Hartley, Marion L, Bade, Najeebah A, Prins, Petra A, Ampie, Leonel, Marshall, John L

“…Although pancreatic cancer is but the eleventh most prevalent cancer in the US, it is predicted that of all the patients newly diagnosed with this disease in…”
Get full text

Benzo[a]pyrene Potentiates the Pathogenesis of Abdominal Aortic Aneurysms in Apolipoprotein E Knockout Mice by Prins, Petra A., Perati, Prudhvidhar R., Kon, Valentina, Guo, Zhongmao, Ramesh, Aramandla, Linton, MacRae F., Fazio, Sergio, Sampson, Uchechukwu K.

“…The objective of this study was to determine the effect of benzo[a]pyrene (BaP), an abundant environmental polycyclic aromatic hydrocarbon compound, on the…”
Get full text

Quantitative Estimates of the Variability of In Vivo Sonographic Measurements of the Mouse Aorta for Studies of Abdominal Aortic Aneurysms and Related Arterial Diseases by Sampson, Uchechukwu K., Perati, Prudhvidhar R., Prins, Petra A., Pham, Wellington, Liu, Zhouwen, Harrell, Frank E., Linton, MacRae F., Gore, John C., Kon, Valentina, Fazio, Sergio

“…Objectives Burgeoning interest in reducing the morbidity and mortality associated with abdominal aortic aneurysms (AAAs) has led to experimental strategies to…”
Get full text

Patients with hepatocellular carcinoma (HCC) who require multiple transarterial chemoembolization (TACE) treatments in quick succession and prediction of outcome by Ouf, Mahmoud, Prins, Petra, Armstrong, Samantha Ann, Singh, Bhavana Pendurthi, Geng, Xue, Wang, Hongkun, Yin, Chao, Sadagopan, Narayanan, He, Aiwu Ruth

“…e16208 Background: TACE has been one of the standard treatments for intermediate-stage HCC patients for over 20 years. The outcome of patients from TACE…”
Get full text

Predictors of immunotherapy (IO) response and subsequent tyrosine kinase inhibitor (TKI) response in hepatocellular carcinoma (HCC) by Armstrong, Samantha Ann, Singh, Bhavana Pendurthi, Kulasekaran, Monika, Prins, Petra, He, Aiwu Ruth

“…Abstract only e16642 Background: Despite advances in understanding the molecular pathways of HCC, therapeutic options are limited and patient survival is…”
Get full text

Low Incidence of Hepatitis B Seropositivity in Inflammatory Bowel Disease Patients Prior to AntiTNF Therapy: P-087 by Alyssa, Damon, Hodges, Mia, Jeremy, Zack, Petra, Prins, Aline, Charabaty

Get full text

Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC by Gabrielson, Andrew, Wu, Yunan, Wang, Hongkun, Jiang, Jiji, Kallakury, Bhaskar, Gatalica, Zoran, Reddy, Sandeep, Kleiner, David, Fishbein, Thomas, Johnson, Lynt, Island, Eddie, Satoskar, Rohit, Banovac, Filip, Jha, Reena, Kachhela, Jaydeep, Feng, Perry, Zhang, Tiger, Tesfaye, Anteneh, Prins, Petra, Loffredo, Christopher, Marshall, John, Weiner, Louis, Atkins, Michael, He, Aiwu Ruth

“…Immune cells that infiltrate a tumor may be a prognostic factor for patients who have had surgically resected hepatocellular carcinoma (HCC). The density of…”
Get more information

Platinum-based therapy of patients with gastrointestinal cancers that harbor homologous recombination DNA damage response (HR-DDR) mutations: A single institutional retrospective analysis by Singh, Bhavana Pendurthi, Ballman, Madison, Drake, Evan, Khanchandani, Ashish, Prins, Petra, Weinberg, Benjamin Adam

“…Abstract only 836 Background: HR-DDR deficiencies have been described across cancer types and associated with response to specific therapies, including…”
Get full text

Predictors of immunotherapy (IO) response in hepatocellular carcinoma (HCC) by Armstrong, Samantha Ann, Singh, Bhavana Pendurthi, Kulasekaran, Monika, Prins, Petra, He, Aiwu Ruth

“…Abstract only 555 Background: Despite advances in understanding the molecular pathways of HCC, therapeutic options are limited and patient survival is dismal…”
Get full text

Predictors of poor outcome for transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC) by Prins, Petra, Singh, Bhavana P, Armstrong, Samantha Ann, He, Aiwu Ruth

“…Abstract only 4100 Background: The use of TACE in select patients with BCLC stage B HCC has been shown to improve survival. Despite this, it remains unclear…”
Get full text

Systemic therapy for advanced hepatocellular carcinoma: an update by Desai, Jasmin Radhika, Ochoa, Sebastian, Prins, Petra Alexandra, He, Aiwu Ruth

“…Advanced hepatocellular carcinoma (HCC) is a deadly disease with few systemic therapeutic options. Sorafenib is the only agent to be FDA approved for the…”
Get full text

Outcome of early and intermediate-stage hepatocellular carcinoma (HCC): A single institution experience at MGUH by Yin, Chao, Armstrong, Samantha Ann, Prins, Petra, Shin, Richard, Shaukat, Fatima, Kulasekaran, Monika, Wang, Hongkun, Satoskar, Rohit P., Smith, Coleman, Kim, Alexander Y., He, Aiwu Ruth

“…Abstract only 328 Background: Liver transplant (LT) remains the best curative standard for HCC within Milan criteria (Milan). Nonsurgical locoregional…”
Get full text

TKIs beyond immunotherapy predict improved survival in advanced HCC by Armstrong, Samantha, Roy, Tina, Singh, Bhavana, Kulasekaran, Monika, Shaukat, Fatima, Geng, Xue, Wang, Hongkun, Prins, Petra, Jha, Reena C., Hartley, Marion L., He, Aiwu Ruth

“…Purpose For patients with advanced HCC, predictors of immunotherapy response are scarce, and the benefits of tyrosine kinase inhibitor (TKI) treatment after…”
Get full text

Molecular profiling to predict outcomes following Y90 radioembolization for metastatic colorectal cancer by Prins, Petra, Gradzka, Alexandra, Kim, Alexander Y., Marshall, John, Unger, Keith Robert

“…Abstract only 686 Background: Radioembolizaton with yttrium-90 (Y90) has been shown to decrease progression within the liver in patients with unresectable…”
Get full text

Safety of Short 30 Minutes Infliximab Infusion: A Pilot Study: P-084 by Alyssa, Damon, Hodges, Mia, Jeremy, Zack, Aimee, LeStrange, Mark, Mattar, Petra, Prins, Aline, Charabaty

Get full text